Deprescribing Antipsychotics in Long-Term Care

NACompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

January 31, 2019

Study Completion Date

August 31, 2019

Conditions
DementiaBehavior
Interventions
OTHER

Intervention

"The intervention will be 12-weeks in duration consisting of four blocks resulting from a 1:1 randomization of two different three-week treatment courses of a patient's existing antipsychotic medication. For example, the intervention ABAB means that a participant would undergo three weeks of treatment A, followed by three weeks of treatment B, followed by three weeks of treatment A, and lastly three weeks of treatment B.~Treatment A block is defined as a mutually agreed upon dose of a participant's antipsychotic medication that is different (i.e. lower) than their enrolment dose.~Treatment B block is defined as a mutually agreed upon dose of a participant's antipsychotic medication that is different (i.e. lower) than their enrolment dose and the dose in Treatment A."

Trial Locations (1)

L9H 3B9

Blackadar Continuing Care Centre, Dundas

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

College of Family Physicians of Canada

OTHER

collaborator

MediSystem Pharmacy

UNKNOWN

lead

McMaster University

OTHER

NCT02958800 - Deprescribing Antipsychotics in Long-Term Care | Biotech Hunter | Biotech Hunter